The incumbent will work under the direction and supervision of James M. Olson, which includes his role as the Director of the Protein Therapeutics Program and Director of the Molecular Design and Therapeutics Core (MDT). Dr. Olson\u2019s laboratory and research program, along with management and oversight of the MDT are situated in the Clinical Research Division (CRD).
The incumbent, in collaboration with Dr. Olson, the Executive Director, CRD, Fred Hutch leadership which includes leaders in Business Development, Advancement (Development), and Communications, along with other scientists and researchers will develop partnerships supporting the Protein Therapeutics Program and MDT Core. In addition, the incumbent will steward all management and administrative responsibilities of the Protein Therapeutics Program and MDT Core.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before ...that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.